Johnson & Johnson

Johnson & Johnson develops, manufactures, and sells a broad range of healthcare products globally. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on prescription drugs for therapeutic areas such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism. The MedTech segment offers products used in surgery, orthopedics, cardiovascular procedures, and vision care. This includes joint reconstruction, trauma, spine, sports medicine, surgical stapling, wound closure, biosurgery, and robotic surgical technologies. Notable brands include ACUVUE contact lenses and TECNIS intraocular lenses for cataract surgery. The company serves hospitals, wholesalers, retailers, and healthcare professionals.

Johnson & Johnson is listed on the New York Stock Exchange (NYSE) under the ticker symbol JNJ. Its shares are traded in US Dollars (USD). As a US-based company, its financial reporting and stock price are denominated in USD, making it accessible to investors on major US exchanges.

Johnson & Johnson operates in the Healthcare sector and is classified under the Drug Manufacturers - General industry. This means the company is primarily involved in the research, development, and production of pharmaceutical drugs and medical devices. Its broad portfolio spans both prescription medicines and medical technology, positioning it as a diversified healthcare leader.

Johnson & Johnson is headquartered in New Brunswick, New Jersey, United States. Founded in 1886, the company serves global markets, distributing its products through retailers, wholesalers, distributors, hospitals, and healthcare professionals worldwide. Its operations cover multiple regions, with a focus on the US and international markets, providing healthcare solutions in areas like oncology, surgery, orthopedics, and vision care.

Johnson & Johnson generates revenue through two main segments: Innovative Medicine and MedTech. The Innovative Medicine segment earns from prescription drugs sold to wholesalers, retailers, hospitals, and healthcare professionals. Key therapeutic areas include oncology, immunology, neuroscience, and cardiovascular diseases. The MedTech segment derives income from medical devices and equipment used in surgery, orthopedics, cardiovascular procedures, and vision care. Products range from joint implants and surgical staplers to contact lenses (ACUVUE) and intraocular lenses (TECNIS). The company also offers digital and robotic technologies for surgical procedures. Its diversified portfolio allows it to capture value across the healthcare value chain.